CRIS Current Research Information System

RIZZELLO, FERNANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.656
AS - Asia 10.555
EU - Europa 7.921
AF - Africa 797
Continente sconosciuto - Info sul continente non disponibili 784
SA - Sud America 707
OC - Oceania 21
Totale 33.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.391
SG - Singapore 2.818
VN - Vietnam 2.746
CN - Cina 2.607
IT - Italia 1.860
GB - Regno Unito 1.634
DE - Germania 941
SE - Svezia 784
HK - Hong Kong 762
FR - Francia 561
BR - Brasile 519
IN - India 474
RU - Federazione Russa 410
UA - Ucraina 350
IE - Irlanda 300
NL - Olanda 230
KR - Corea 214
FI - Finlandia 203
ZA - Sudafrica 196
CI - Costa d'Avorio 183
JP - Giappone 181
SC - Seychelles 162
BD - Bangladesh 155
TG - Togo 154
CH - Svizzera 117
BG - Bulgaria 109
EE - Estonia 108
JO - Giordania 108
CA - Canada 105
AR - Argentina 92
PH - Filippine 82
BE - Belgio 67
ES - Italia 53
MX - Messico 52
IQ - Iraq 51
ID - Indonesia 50
PL - Polonia 50
TH - Thailandia 42
TR - Turchia 41
HN - Honduras 39
TW - Taiwan 38
AT - Austria 36
SA - Arabia Saudita 30
GR - Grecia 27
PK - Pakistan 27
UZ - Uzbekistan 27
NG - Nigeria 24
EC - Ecuador 20
CL - Cile 19
IR - Iran 19
AU - Australia 18
BZ - Belize 18
CO - Colombia 16
EG - Egitto 15
PY - Paraguay 15
CZ - Repubblica Ceca 14
JM - Giamaica 14
LT - Lituania 14
RO - Romania 13
ET - Etiopia 12
VE - Venezuela 12
MY - Malesia 11
LB - Libano 10
MA - Marocco 10
TN - Tunisia 9
HR - Croazia 8
KE - Kenya 8
PT - Portogallo 8
IL - Israele 7
KZ - Kazakistan 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CR - Costa Rica 6
DZ - Algeria 6
BF - Burkina Faso 5
BO - Bolivia 5
EU - Europa 5
PE - Perù 5
PS - Palestinian Territory 5
AL - Albania 4
DO - Repubblica Dominicana 4
MD - Moldavia 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
MN - Mongolia 3
NI - Nicaragua 3
RS - Serbia 3
BB - Barbados 2
BW - Botswana 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 32.626
Salva come PNG Salva come JPEG
Città #
Singapore 1.930
Ashburn 1.402
Southend 1.351
Fairfield 1.054
Chandler 836
Hong Kong 713
San Jose 697
Ho Chi Minh City 602
Santa Clara 538
Woodbridge 530
Houston 503
Hanoi 488
Hefei 481
Wilmington 459
Seattle 434
Princeton 386
Beijing 383
Cambridge 346
Bologna 337
Dong Ket 326
Ann Arbor 325
Dublin 299
Council Bluffs 277
Boardman 249
Lauterbourg 216
Abidjan 183
New York 180
Jacksonville 179
Seoul 178
Los Angeles 172
Nanjing 171
Helsinki 169
Lomé 154
Tokyo 153
Westminster 148
Milan 140
Padova 123
Berlin 122
Buffalo 111
Sofia 108
Amman 107
San Diego 101
Dallas 99
Frankfurt am Main 98
Bern 92
Rome 86
Da Nang 85
Haiphong 84
São Paulo 81
Turin 78
Shenyang 75
Redondo Beach 71
Jinan 70
Saint Petersburg 66
Guangzhou 65
Phoenix 65
Johannesburg 64
Changsha 58
Munich 57
Bengaluru 52
Hebei 50
Shanghai 50
Brussels 48
Orem 46
Redwood City 44
Mülheim 43
Medford 41
Redmond 39
London 38
Nanchang 38
Chicago 36
Des Moines 36
Bremen 35
Florence 34
Nuremberg 34
San Francisco 34
Tianjin 34
Yubileyny 34
Atlanta 33
Dearborn 33
Henderson 33
Falkenstein 28
Montreal 28
Zhengzhou 28
Hangzhou 27
Saint Louis 27
Centro 26
Falls Church 26
Hải Dương 26
Jiaxing 26
Can Tho 25
Toronto 25
Biên Hòa 24
Boston 24
Mahé 24
Modena 24
Norwalk 24
Thái Nguyên 23
Warsaw 23
Washington 23
Totale 20.301
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 687
Ulcerative Colitis 378
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 326
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 312
COVID-19 in IBD: The experience of a single tertiary IBD center 311
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 272
Adult attachment and early parental experiences in patients with Crohn’s Disease 265
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 255
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 250
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 248
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 245
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 240
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 239
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 234
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 229
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 229
Medical treatment and management of severe ulcerative colitis 226
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 225
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 221
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 219
Infliximab in the treatment of Crohn's disease 218
Attachment and quality of life in patients with inflammatory bowel disease 218
Cyclooxygenase-2 Silencing for the Treatment of Colitis: A Combined In Vivo Strategy Based on RNA Interference and Engineered Escherichia Coli 217
Adalimumab in active ulcerative colitis: a "real-life" observational study. 216
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 215
High-dose probiotics for the treatment of active pouchitis 213
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 213
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 208
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 202
Implications of the westernized diet in the onset and progression of IBD 202
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 202
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 201
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 201
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 200
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 200
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study 199
Implications of antioxidant enzymes in human gastric neoplasms 198
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 196
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 196
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 195
Clinical course of microscopic colitis in a single-center cohort study 193
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 193
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 193
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 191
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 191
Percutaneous abdomino-pelvic abscess drainage in complicated Crohn’s disease 190
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 190
Antibiotics and probiotics in treatment of inflammatory bowel disease 189
Oral budesonide in the treatment of chronic refractory pouchitis. 188
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 188
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 188
Management and treatment of distal ulcerative colitis 188
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 188
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 187
Management of inflammatory bowel disease: does rifaximin offer any promises 186
Review article: aminosalicylates for distal colitis 184
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 184
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 183
Probiotics in IBD: A critical review 183
Role of Biologics in refractory pouchitis 182
Parental Bonding and Inflammatory Bowel Disease 182
Role of conventional therapies in the era of biological treatment in Crohn's disease. 182
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 181
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 179
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 179
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 178
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 177
MANAGEMENT OF POUCHITIS 176
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 175
The role of Budesonide-MMX in active ulcerative colitis. 175
Pre-pouch ileitis 173
Antimicrobials in the management of inflammatory bowel disease 173
Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients 172
Which therapies are advisable in pouchitis? 172
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 172
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 172
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 171
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 171
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 170
Sympathetic hyperactivity in patients with ulcerative colitis. 168
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 168
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 167
A current overview of corticosteroid use in active ulcerative colitis 166
Randomized controlled trials in pouchitis 165
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 165
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 164
Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis 164
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 163
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 163
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 163
Problematic proctitis and distal colitis 163
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 163
The Bidirectional Link between Nutritional Factors and Inflammatory Bowel Diseases: Dietary Deficits, Habits, and Recommended Interventions-A Narrative Review 162
Oral beclomethasone dipropionate in chronic refractory pouchitis 162
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 160
DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre 160
Probiotics, Prebiotics, and Antibiotics in IBD 159
Rescue therapy: ciclosporin or infliximab? 159
The contribution of ultrasound in the diagnostic pathway of a symptomatic hepatocellular adenoma arising from ectopic liver 157
Totale 20.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.961 0 93 217 160 295 168 83 194 202 236 817 496
2022/20233.789 396 510 184 460 247 316 102 209 736 104 269 256
2023/20241.219 80 199 109 92 95 290 73 76 35 65 46 59
2024/20254.588 248 686 388 291 720 225 284 160 108 339 215 924
2025/202611.425 1.021 1.124 966 830 1.239 701 1.141 372 2.228 966 499 338
2026/2027645 292 353 0 0 0 0 0 0 0 0 0 0
Totale 33.441